GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nitric oxide reductase flrd- NAD(+) reductase (B5FG80)

Analyse AlphaFold monomer V2.0 prediction for nitric oxide reductase flrd- NAD(+)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B5FG80
Type
protein
Length
381 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x04de7B7fF3D4429895E28Ed9F5d790AD0196Da63
Molecule
Nitric oxide reductase flrd-NAD(+) reductase
UniProt
B5FG80
Pockets
1 · best druggability 0.78

Structure

1 distinct chain · 27% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric oxide reductase flrd-NAD(+) reductaseprotein38127% helix, 31% strandB5FG80

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110760.780.80106empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.